Form 4 Tracker
Xenon Pharmaceuticals Inc.
XENE

16 insider filings · Latest: Jun 5, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Dec 5, 2025Dec 5 10:54 PMIAN MORTIMER
Proposed Sale
14,375$45.03$647.4K

View →

Nov 28, 2025Dec 2 12:36 AMIAN MORTIMER
Proposed Sale
97$45.01$4.4K

View →

Oct 1, 2025Oct 1 11:13 PMIAN MORTIMER
Proposed Sale
25,000$40.16$1.0M

View →

Sep 19, 2025Sep 20 1:10 AMSHERRY AULIN
Proposed Sale
2,548$37.08$94.5K

View →

Jan 27, 2025Jan 28 1:25 AMIAN MORTIMER
Proposed Sale
16,315$40.50$660.8K

View →

Jan 24, 2025Jan 24 10:13 PMIAN MORTIMER
Proposed Sale
22,468$40.20$903.3K

View →

Jan 23, 2025Jan 23 11:34 PMIAN MORTIMER
Proposed Sale
16,217$40.08$649.9K

View →

Dec 18, 2024Dec 18 10:50 PMSHERRY AULIN
Proposed Sale
18,709$41.21$770.9K

View →

Nov 22, 2024Nov 22 11:55 PMGARY PATOU
Proposed Sale
4,891$41.08$200.9K

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 9, 2026Mar 11 11:20 PMAndrea DifabioChief Legal Officer
Option Exercise
7,5000(D)

View →

Mar 9, 2026Mar 11 11:20 PMAndrea DifabioChief Legal Officer
Grant/Award
7,5007,500(D)

View →

Mar 9, 2026Mar 11 11:20 PMIan MortimerDirector, PRESIDENT & CEO
Grant/Award
20,00020,000(D)

View →

Mar 9, 2026Mar 11 11:20 PMIan MortimerDirector, PRESIDENT & CEO
Option Exercise
290,000$9.440(D)

View →

← Previous

Page 2 of 2